Skip to content

What is the effect of individualized homoeopathic medicine as an add on therapy in the management and improvement of quality of life among geriatric patients with frailty syndrome

Effectiveness of Individualized Homoeopathic Medicine as an add on therapy on management and improvement in quality of life among geriatric patients with frailty syndrome A Placebo controlled experimental study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091984
Enrollment
120
Registered
2025-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R54- Age-related physical debility

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: HOMOEOPATHIC MEDICINE WITH INDICATED POTENCY AND FREQUENCY Control Intervention1: PLACEBO: PLACEBO WILL BE GIVEN AS AN ADD N THERAPY TO SEE THE E

Sponsors

Dr.M.L.Dhawale Memorial Homoeopathic Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group 65 and above Patients of all genders Patients taking treatment with or without co -morbidities will be included

Exclusion criteria

Exclusion criteria: Patients who are suffering from carcinoma and suspected immune-compromised. Patients of CKD who are on dialysis will be excluded

Design outcomes

Primary

MeasureTime frame
To study the effectiveness of Individualized Homoeopathic Medicines as an add on therapy in comparison to placebo group on management and improvement in quality of life in geriatric patients with frailty syndrome using FRAIL questionnaire and WHO QOL BREF scale for up to 9 months or if remission occurs whichever is earlierTimepoint:

Secondary

MeasureTime frame
To compare the Pre & Post treatment values of FRAIL questionnaire & WHO QOL BREF scale in comparison to placebo group among geriatric patients with frailty syndrome which will be applied in study for 9 months or if remission occurs whichever is earlierTimepoint: baseline, 3 months, 6 months, 9 months

Countries

India

Contacts

Public ContactDr Sachin Chokakkar

Y.M.T. Homoeopathic college, Kharghar, Navi Mumbai

newbeginingsach@yahoo.com09172488888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026